HDAC6 and ovarian cancer: These aloxyurea derivatives, which contained structural similarity with ricolinostat, depicted selective inhibition of HDAC-1 and HDAC-6 over other HDACs and also displayed satisfactory inhibitory potential against ovarian cancer cells A2780 and A2780CisR.